sabinene has been researched along with Disbacteriosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 6 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bosco, F; Carresi, C; Gliozzi, M; Macri, R; Maiuolo, J; Mollace, V; Muscoli, C; Musolino, V; Nucera, S; Oppedisano, F; Palma, E; Scarano, F; Scicchitano, M | 1 |
| Kim, H; Kim, HJ; Kim, YS; Seo, KH; Youn, HY | 1 |
| Cai, YY; Chen, BZ; Chu, C; Li, J; Li, P; Li, SZ; Liu, EH; Xiao, PT; Zeng, SL | 1 |
| Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
| Chen, Z; Cui, D; He, B; Jiang, J; Luo, M; Shi, Z; Wu, L; Xu, S; Yan, J; Yan, M; Zhang, S | 1 |
| Ho, CT; Li, S; Wang, M; Wen, X; Zhao, H | 1 |
| Jiang, JG; Shen, CY; Wan, L; Wang, TX | 1 |
2 review(s) available for sabinene and Disbacteriosis
| Article | Year |
|---|---|
Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis:
Topics: Aloe; Animals; Citrus; Dysbiosis; Gastrointestinal Microbiome; Humans; Mammals; Multiple Sclerosis; Verrucomicrobia | 2022 |
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
5 other study(ies) available for sabinene and Disbacteriosis
| Article | Year |
|---|---|
Effect of postbiotics derived from kefir lactic acid bacteria-mediated bioconversion of citrus pomace extract and whey on high-fat diet-induced obesity and gut dysbiosis.
Topics: Animals; Butyrates; Citrus; Diet, High-Fat; Dysbiosis; Kefir; Lactobacillales; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Whey; Whey Proteins | 2022 |
Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism.
Topics: Amino Acids; Animals; Citrus; Dysbiosis; Feces; Flavones; Gastrointestinal Microbiome; Humans; Insulin Resistance; Metabolic Syndrome; Metabolome; Mice; Obesity; Prebiotics | 2020 |
Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
Topics: Animals; Bacteria; Bile Acids and Salts; Citrus; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Flavonoids; Gastrointestinal Microbiome; Intestines; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Plant Extracts; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |
Citrus flavonoids and the intestinal barrier: Interactions and effects.
Topics: Citrus; Dysbiosis; Flavonoids; Gastrointestinal Microbiome; Microbiota | 2021 |
Citrus aurantium L. var. amara Engl. inhibited lipid accumulation in 3T3-L1 cells and Caenorhabditis elegans and prevented obesity in high-fat diet-fed mice.
Topics: 3T3-L1 Cells; Animals; Anti-Obesity Agents; Caenorhabditis elegans; Cell Differentiation; Citrus; Diet, High-Fat; Dysbiosis; Fatty Liver; Flavonoids; Flowers; Gastrointestinal Microbiome; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Reactive Oxygen Species | 2019 |